Navigation Links
Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
Date:9/13/2007

e connect to Arena's website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's strategy, preclinical and internal and partnered clinical programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, Arena's planned clinical trials may not proceed at the time Arena expects or at all, the results of preclinical studies or clinical trials may not be predictive of future results, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 PuraMed BioScience ® , Inc., ... (OTC) medicinal and healthcare products, announced today that ... along with the name,s red and yellow logo. ... name MigraPure ®  going forward. The new ... natural migraine pain reliever will be reintroduced into ...
(Date:7/30/2014)... 2014 Research and Markets has announced the ... to 2019" report to their offering. ... grow at a lower CAGR in developed countries; however, it is ... China , India , and ... The growth of the hematology analyzers and reagents market is driven ...
(Date:7/30/2014)... 2014  Today the US Surgeon General issued the most ... or sun burns stating they can lead directly to deadly ... Lushniak , says that "skin cancer is a major public ... exposure to indoor and outdoor ultraviolet light is a major ... in Boca Raton, Florida , Marta ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Hematology Analyzers & Reagents Market - Forecasts to 2019 2Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2
(Date:7/30/2014)... (PRWEB) July 30, 2014 ... China Chitosan Industry” is a professional and ... market. The report provides basic Chitosan information, ... chain structure as well as industry overview. ... China’s domestic market as well as global ...
(Date:7/30/2014)... York, NY (PRWEB) July 30, 2014 Frozen ... Women are more likely to develop this nasty condition which ... and 60, and can last up to two and half ... known as frozen shoulder, and with good reason: it can ... your shirt — that is, if you aren't in too ...
(Date:7/30/2014)... July 30, 2014 The report "Peracetic ... by Application (Healthcare, Food, Water Treatment, Pulp & Paper, ... ROW) - Global Trends & Forecasts to 2018". Peracetic ... of 229.54 kilotons by 2019, signifying a robust growth ... , Browse 83 market data tables and 33 figures ...
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- For patients ... is enough to trigger airway inflammation for at least ... just what you smell, but also what you think ... Monell Chemical Senses Center in Philadelphia, said in a ... about scents and fragrances. When we expect that an ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, ... help soothe the agitation that commonly strikes people with dementia, ... British researchers found evidence that watering plants, or sitting or ... anxiety. The study authors cautioned that the effects of ... -- and the evidence of a benefit is limited. But ...
Breaking Medicine News(10 mins):Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 2Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 3Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 4Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 2Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 3Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2Health News:Gardens a Center of Calm for People With Dementia 2Health News:Gardens a Center of Calm for People With Dementia 3
... 22 ResMed Inc. (NYSE: RMD ), announced ... its results for the third quarter and nine months of ... with ResMed,s results will be issued after 1:00 p.m. Pacific ... webcast to review its results, market trends, and future outlook.The ...
... study finds older people taking NSAIDs more likely to suffer ... suggested that older people who want to avoid Alzheimer,s disease ... ibuprofen and naproxen, but a new study suggests that might ... ,Should I take these to prevent dementia?, the answer ...
... BALTIMORE, April 22 XLHealth, owner and operator of ... Advantage chronic condition Special Needs Plans, supports the proposed ... in the first of a series of round-table discussions ... The hearing,s focus on using the Medicare system as ...
... professional groups join with Congressional sponsors Reps. Israel, Brady ... access to IVIGWASHINGTON, April 22 Members ... introduction of new legislation - H.R. 2002, Medicare Patient ... inadequate Medicare reimbursements that currently restrict patient access to ...
... Study finds no link to condition that can increase ... Soy isoflavones don,t increase breast density, a new study ... increased breast density is associated with a higher risk ... that dietary factors, including isoflavones (estrogen-like plant compounds) might ...
... New York Times best-selling author and mother of five ... special family gathering to celebrate her status as a mom. Instead, ... seeking favors and just plain hard work. Novak,s 5th Annual Online ... May is a labor of love for her son who has ...
Cached Medicine News:Health News:ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results 2Health News:Painkillers May Not Protect Against Dementia 2Health News:Painkillers May Not Protect Against Dementia 3Health News:XLHealth Statement on Senate Finance Committee Roundtable on Healthcare Reform 2Health News:New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 2Health News:New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 3Health News:New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin 4Health News:NY Times Best-Selling Author Brenda Novak Gives Annual Mother's Day Gift of Hope to Diabetic Son and Others 2Health News:NY Times Best-Selling Author Brenda Novak Gives Annual Mother's Day Gift of Hope to Diabetic Son and Others 3Health News:NY Times Best-Selling Author Brenda Novak Gives Annual Mother's Day Gift of Hope to Diabetic Son and Others 4
... Single Use reloadable linear stapler for resection, ... ,The Auto Suture™ MULTIFIRE GIA™ 60 and ... GIA™ 60 and 80 single use loading ... 60 knifeless single use surgical stapler with ...
... Loading Units With Titanium Staples ... (Single Use Reloadable Staplers With ... ILA™ 75 single-use stapler, anastomotic ... in the resection, transection, and/or ...
... The PROXIMATE HCS Procedure for Prolapse ... rows of titanium staples in 33mm diameter ... anal canal for transection and resection of ... the surgical treatment of hemorrhoidal disease. The ...
The Reusable Purse String Clamp is intended for use in the mechanical construction of a purse string suture. The clamp can be used on any part of the gastrointestinal tract except the esophagus....
Medicine Products: